New Global Consortium Aims to Transform Antibiotic Discovery to Counter the Growing AMR Crisis
The Bill & Melinda Gates Foundation, alongside the Novo Nordisk Foundation and Wellcome, announced $60 million in new global grant funding over three years to accelerate antibiotic discovery against antimicrobial resistance (AMR) through a first-of-its-kind consortium, the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), which will support 18 research projects in 17 countries focused on developing new antibiotics for Gram-negative bacteria, with open data sharing and collaboration designed to overcome current scientific and market barriers and address the urgent global health threat of AMR.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!
